Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS
· Delayed Price · Currency is USD
26.00
+7.50 (40.54%)
At close: Nov 13, 2025
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
$482,221
Profits / Employee
$20,495
Market Cap
32.65B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35,686 | -786 | -2.16% |
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% |
| Dec 31, 2022 | 35,125 | -854 | -2.37% |
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% |
| Dec 31, 2020 | 38,372 | -1,667 | -4.16% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Teva Pharmaceutical Industries News
- 1 day ago - Teva Pharmaceutical Industries Ltd at Citi Global Healthcare Conference Transcript - GuruFocus
- 1 day ago - Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 1 day ago - Israel Has Been Mired In Controversy During Its War With Hamas. Big Tech Investment Tells A Different Story. - Investor's Business Daily
- 2 days ago - TEVA Forecasts Significant Rise in Cash Flow by 2030 - GuruFocus
- 3 days ago - Noteworthy ETF Inflows: IEFA, SPOT, SE, TEVA - Nasdaq
- 6 days ago - 30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks - The Motley Fool
- 8 days ago - Is the Market Bullish or Bearish on Teva Pharmaceutical Industries Ltd? - Benzinga
- 10 days ago - Teva: European Commission Grants Marketing Authorizations For Biosimilars PONLIMSI, DEGEVMA - Nasdaq